1. Hurt KJ, Guile MW, Bienstock JL, Fox HE, Wallach EE. The Johns Hopkins manual of gynecology and obstetrics. 4th ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2011.
2. National Collaborating Centre for Women's and Children's Health (GB). National Institute for Health and Clinical Excellence (GB). Royal College of Obstetricians and Gynaecologists (GB). Ectopic pregnancy and miscarriage: diagnosis and initial management in early pregnancy of ectopic pregnancy and miscarriage. London (GB): Royal College of Obstetricians and Gynaecologists; 2012.
3. Francis O. An analysis of 1150 cases of abortions from the Government R.S.R.M. Lying-in Hospital, Madras. J Obstet Gynaecol India 1959;10:62-70. PMID:
12336441.
4. Cunningham FG. Williams obstetrics. 24th ed. New York (NY): McGraw-Hill; 2014.
5. Oliver A, Overton C. Diagnosis and management of miscarriage. Practitioner 2014;258:25-28. 23.
6. Kripke C. Expectant management vs. surgical treatment for miscarriage. Am Fam Physician 2006;74:1125-1126. PMID:
17039747.
7. Tunçalp Ö, Gülmezoglu AM, Souza JP. Surgical procedures for evacuating incomplete miscarriage. Cochrane Database Syst Rev 2010;CD001993. PMID:
20824830.
8. Schaff EA, Stadalius LS, Eisinger SH, Franks P. Vaginal misoprostol administered at home after mifepristone (RU486) for abortion. J Fam Pract 1997;44:353-360. PMID:
9108832.
9. Westhoffa C, Dasmahapatra R, Schaff E. Analgesia during at-home use of misoprostol as part of a medical abortion regimen. Contraception 2000;62:311-314. PMID:
11239618.
10. Creinin MD, Schreiber CA, Bednarek P, Lintu H, Wagner MS, Meyn LA, et al. Mifepristone and misoprostol administered simultaneously versus 24 hours apart for abortion: a randomized controlled trial. Obstet Gynecol 2007;109:885-894. PMID:
17400850.
11. Kopp Kallner H, Fiala C, Gemzell-Danielsson K. Assessment of significant factors affecting acceptability of home administration of misoprostol for medical abortion. Contraception 2012;85:394-397. PMID:
22067756.
12. Tang J, Kapp N, Dragoman M, de Souza JP. WHO recommendations for misoprostol use for obstetric and gynecologic indications. Int J Gynaecol Obstet 2013;121:186-189. PMID:
23433680.
13. Zieman M, Fong SK, Benowitz NL, Banskter D, Darney PD. Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol 1997;90:88-92. PMID:
9207820.
14. Bracken H, Dabash R, Tsertsvadze G, Posohova S, Shah M, Hajri S, et al. A two-pill sublingual misoprostol outpatient regimen following mifepristone for medical abortion through 70 days’ LMP: a prospective comparative open-label trial. Contraception 2014;89:181-186. PMID:
24332431.
15. Chong E, Tsereteli T, Nguyen NN, Winikoff B. A randomized controlled trial of different buccal misoprostol doses in mifepristone medical abortion. Contraception 2012;86:251-256. PMID:
22305917.
16. Tang OS, Lau WN, Ng EH, Lee SW, Ho PC. A prospective randomized study to compare the use of repeated doses of vaginal with sublingual misoprostol in the management of first trimester silent miscarriages. Hum Reprod 2003;18:176-181. PMID:
12525463.
17. Schaff EA, Fielding SL, Westhoff C. Randomized trial of oral versus vaginal misoprostol at one day after mifepristone for early medical abortion. Contraception 2001;64:81-85. PMID:
11704083.
18. Aronsson A, Bygdeman M, Gemzell-Danielsson K. Effects of misoprostol on uterine contractility following different routes of administration. Hum Reprod 2004;19:81-84. PMID:
14688161.
19. Tang OS, Lau WN, Chan CC, Ho PC. A prospective randomised comparison of sublingual and vaginal misoprostol in second trimester termination of pregnancy. BJOG 2004;111:1001-1005. PMID:
15327617.
20. Kulier R, Kapp N, Gülmezoglu AM, Hofmeyr GJ, Cheng L, Campana A. Medical methods for first trimester abortion. Cochrane Database Syst Rev 2011;CD002855. PMID:
22071804.
21. Cunningham FG. Williams obstetrics. 23rd ed. New York (NY): McGraw-Hill; 2010.
22. Bracken H. Family Planning Association of India (FPAI)/Gynuity Health Projects Research Group for Simplifying Medical Abortion in India. Home administration of misoprostol for early medical abortion in India. Int J Gynaecol Obstet 2010;108:228-232. PMID:
19945104.
23. Kopp Kallner H, Fiala C, Stephansson O, Gemzell-Danielsson K. Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days. Hum Reprod 2010;25:1153-1157. PMID:
20172871.
24. Hofmeyr GJ, Gülmezoglu AM, Pileggi C. Vaginal misoprostol for cervical ripening and induction of labour. Cochrane Database Syst Rev 2010;CD000941. PMID:
20927722.
25. Gómez Ponce de León R, Wing D, Fiala C. Misoprostol for intrauterine fetal death. Int J Gynaecol Obstet 2007;99(Suppl 2):S190-S193. PMID:
17961568.
26. Karki DB, Sharmqa UK, Rauniyar RK. Study of accuracy of commonly used fetal parameters for estimation of gestational age. JNMA J Nepal Med Assoc 2006;45:233-237. PMID:
17189967.
27. Yu D, Wong YM, Cheong Y, Xia E, Li TC. Asherman syndrome--one century later. Fertil Steril 2008;89:759-779. PMID:
18406834.
28. Engelbrechtsen L, Langhoff-Roos J, Kjer JJ, Istre O. Placenta accreta: adherent placenta due to Asherman syndrome. Clin Case Rep 2015;3:175-178. PMID:
25838908.
29. von Hertzen H, Baird D; Bellagio Study and Conference Center. Frequently asked questions about medical abortion. Contraception 2006;74:3-10. PMID:
16781252.